Sachs Bruce I's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Apr 14, 2023
- Accession no.
- 0001209191-23-024305
- Filed
- Apr 14, 2023
- Trade date
- Apr 12-13, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.96M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sachs Bruce ICIK 0001197036 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 | Common Stock | MOption exerciseAcquired | +21,300 | $72.14 | +$1,536,582 | 62,510 | Direct | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −2,917 | $325.65F2,F3 | −$949,921.05 | 59,593 | Direct | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −10,357 | $326.46F2,F4 | −$3,381,146.22 | 49,236 | Direct | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −8,026 | $327.48F2,F5 | −$2,628,354.48 | 41,210 | Direct | |
| Apr 13, 2023 | Common Stock | GGiftDisposed | −1,210 | $0.00 | $0 | 40,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 | Common Stock | MOption exerciseDisposed | −21,300 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $325.65 (range $325.00 to $325.99).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $326.46 (range $326.00 to $326.97).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $327.48 (range $327.00 to $327.93).
Referenced by the price of 1 transaction in Table I.